Co-Authors
This is a "connection" page, showing publications co-authored by Adrian Shields and Mark Drayson.
Connection Strength
1.228
-
Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays. J Infect. 2021 Oct; 83(4):e18-e20.
Score: 0.240
-
COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals. J Dent Res. 2021 10; 100(11):1220-1227.
Score: 0.237
-
Health Care Professionals' Confidence and Preferences for Diagnostic Assays for SARS-CoV-2: A Global Study. Front Public Health. 2021; 9:569315.
Score: 0.233
-
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020 12; 75(12):1089-1094.
Score: 0.226
-
Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021 08; 205(2):99-105.
Score: 0.059
-
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva. Immunology. 2021 09; 164(1):135-147.
Score: 0.059
-
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome. Pediatr Allergy Immunol. 2021 07; 32(5):1125-1129.
Score: 0.059
-
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients. J Immunol Methods. 2021 07; 494:113046.
Score: 0.059
-
Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples. Emerg Infect Dis. 2020 12; 26(12):2970-2973.
Score: 0.057